Showing results (141-150 of 311) with videos related to
Sort By:
Pageof 32
Nephrologie|January 1, 1986
[Plasma binding of drugs in chronic renal failure]P Riant, J Barre, E Albengres, et al.British Journal of Clinical Pharmacology|November 1, 1989
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseasesJ L Pinquier, S Urien, P Chaumet-Riffaud, et al.Biochemical Pharmacology|July 15, 1988
Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugsM O Decroix, R Zini, J C Chaumeil, et al.Biochemical Pharmacology|November 3, 1992
Comparative binding of etretinate and acitretin to plasma proteins and erythrocytesS Urien, P Claudepierre, J Meyer, et al.Journal of Receptor Research|January 1, 1992
Labelling of rat brain beta-adrenoceptors: (3H)CGP-12177 or (125I)iodocyanopindolol?D Morin, R Zini, S Urien, et al.FEBS Letters|April 27, 2001
Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidationD Morin, S Barthélémy, R Zini, et al.Biochemical Pharmacology|November 15, 1983
Binding of propranolol and iodocyanopindolol to isolated cells, homogenates and plasma membranes of rat liver, lung, kidney and heartR Zini, I Gault, S Ledewyn, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparative serum protein binding of anthracycline derivativesO Chassany, S Urien, P Claudepierre, et al.European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1995
Bioequivalence study of two pharmaceutical forms of rifampicin capsules in manN Chouchane, J Barre, A Toumi, et al.Investigational New Drugs|January 1, 1995
Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytesS Urien, P Nguyen, G Bastian, et al.Pageof 32